Transluminal delivery of regenerative cells to body tissue
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
N/A
app pub date -
May 13, 2013
filing date -
Sep 30, 2001
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A method is described for optimizing regenerative cell retention at a tissue site in the body of a subject. In the method, the regenerative cells are delivered to the tissue site through a blood vessel in communication with the site, while blood flow through the vessel is occluded at the site for a prescribed period of sufficient duration to increase pressure at the site for enhanced concentration and retention of the regenerative cells at the tissue site, but of insufficient duration to cause damage to healthy tissue at the site for lack of blood perfusion during the period of occlusion.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully